Iontcho Vlahov PhD

Dr. Vlahov’s main scientific interest is the design and synthesis of complex biologically active molecules. In the past 15 years, as the head of Endocyte’s Discovery Chemistry department, Dr.Vlahov has been active in the discovery of personalized targeted approaches for the treatment of cancer and inflammatory diseases. His research efforts are aimed toward finding novel small molecule drug conjugates, linker systems, spacer units, and highly potent warheads. To date, these programs led to the development of four clinically investigated agents (the most advanced is currently in global Phase 3 trials and has been granted Conditional Marketing Authorization in Europe